Pakistan approves emergency use of third Chinese COVID-19 vaccine despite low efficacy rate
The Hindu
The Drug Regulatory Authority of Pakistan granted Emergency Use Authorisation to CoronaVac, developed by Chinese company Sinovac Biotech, officials said.
Pakistan has approved the emergency use of the third Chinese vaccine, despite its low efficacy rate, as the country struggled to contain the spread of the coronavirus. The Drug Regulatory Authority of Pakistan (DRAP) on Thursday granted Emergency Use Authorisation (EUA) to CoronaVac, developed by Chinese company Sinovac Biotech, officials said on Saturday. “This is the third Chinese vaccine allowed to be used in Pakistan,” a DRAP official said, adding that the country now has five approved vaccines.More Related News